This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Compared to Estimates, Omega Healthcare Investors (OHI) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Omega Healthcare Investors (OHI) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Omega Healthcare Investors (OHI) Tops Q2 FFO Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of +2.67% and -5.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Terreno Realty's Rent Rises in Q2, Occupancy Improves Y/Y
by Zacks Equity Research
TRNO's Q2 update highlights rent growth and improved occupancy year over year amid healthy demand for industrial real estate assets.
Four Corners Acquires LongHorn Steakhouse Property for $2.5M
by Zacks Equity Research
FCPT continues to expand its portfolio and acquires LongHorn Steakhouse property in Michigan.
Is it Wise to Retain Host Hotels Stock in Your Portfolio Now?
by Zacks Equity Research
HST to gain from its luxury hotel portfolio, strategic capital recycling and a healthy balance sheet. Macroeconomic uncertainty and high interest expenses ail.
Medical Properties Stock Gains 14% in 6 Months: Will the Trend Last?
by Zacks Equity Research
MPW is well-poised to gain from an aging population and a rise in senior citizens' healthcare expenditures, long-term leases and a healthy balance sheet position.
Terreno Realty Announces Leases in California, Sees Healthy Demand
by Zacks Equity Research
TRNO's securing of a renewal and expansion leases at Santa Clara, CA, with a designer and developer of eVTOL aircraft, highlights healthy demand for its properties.
June Jobs Data Puts Focus on Healthcare ETFs & Stocks
by Sanghamitra Saha
June's solid jobs report, with 39K new roles in healthcare, may boost the outlook for ETFs like XLV, IHF, VHT and stocks like HCA, WELL, OHI.
CIO vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
CIO vs. OHI: Which Stock Is the Better Value Option?
Terreno Realty Expands Portfolio With Property Buyout in Queens
by Zacks Equity Research
TRNO's recent spate of acquisitions of industrial properties is likely to aid it in banking on solid industrial real estate market tailwinds.
Compared to Estimates, Omega Healthcare Investors (OHI) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Omega Healthcare Investors (OHI) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Omega Healthcare Investors (OHI) Q1 FFO Match Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 0% and 5.02%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Ventas (VTR) Beats Q1 FFO and Revenue Estimates
by Zacks Equity Research
Ventas (VTR) delivered FFO and revenue surprises of 2.44% and 4.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
INN or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
INN vs. OHI: Which Stock Is the Better Value Option?
Prologis (PLD) Q1 FFO and Revenues Top Estimates
by Zacks Equity Research
Prologis (PLD) delivered FFO and revenue surprises of 2.90% and 2.68%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Alexander's (ALX) Surges 4.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Alexander's (ALX) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might not help the stock continue moving higher in the near term.
DRH or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DRH vs. OHI: Which Stock Is the Better Value Option?
Compared to Estimates, Omega Healthcare Investors (OHI) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Omega Healthcare Investors (OHI) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Omega Healthcare Investors (OHI) Surpasses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 1.37% and 0.27%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
CHCT or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CHCT vs. OHI: Which Stock Is the Better Value Option?
CIO vs. OHI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CIO vs. OHI: Which Stock Is the Better Value Option?
CIO or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CIO vs. OHI: Which Stock Is the Better Value Option?
PEB or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PEB vs. OHI: Which Stock Is the Better Value Option?
Omega Healthcare Investors (OHI) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Omega Healthcare Investors (OHI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Omega Healthcare Investors (OHI) Q3 FFO and Revenues Beat Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 4.23% and 5.50%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?